BIONTECH REPORTS $721M LOSS IN 2024 AS COVID-19 VACCINE DEMAND DROPS
Tue 11 March 2025: German biotech firm BioNTech reported a loss of €665.3 million ($721 million) in 2024, as demand for its COVID-19 vaccines fell, according to the company’s financial results report on Monday. The company, which posted a €930.3 million profit in 2023, failed to make a profit in a fiscal year for the […]
Continue Reading